Latest news

Insights

Top 10 Metrics Pharma Leaders Should Track During Digital Transformation

Executive Summary Digital transformation has become one of the pharmaceutical industry's most significant strategic priorities. Companies are investing billions in...
Uncategorized

Sarclisa Escena Wins FDA Approval for Subcutaneous Use in Multiple Myeloma

Sanofi has received approval from the U.S. Food and Drug Administration for Sarclisa Escena, a subcutaneous formulation of its...
Clinical

Bausch + Lomb Ends BL1107 Glaucoma Program After Phase 2 Trial Misses Main Goal

Bausch + Lomb has decided to discontinue development of its investigational glaucoma eye drop BL1107 after the treatment failed...
Research & Development

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

The Advanced Research Projects Agency for Health (ARPA-H) has announced a new round of funding through its THRIVE program,...
Insights

The Return of M&A as a Growth Strategy in Biopharma

Executive Summary Mergers and acquisitions (M&A) have long played a...
Insights

Top 10 Reasons Pharma Companies Are Building Internal AI Governance Teams

Executive Summary Artificial intelligence (AI) is rapidly becoming embedded across...
Insights

Why Traditional Pharma Marketing Models Are Being Rewritten

Traditional Pharma:Executive Summary The pharmaceutical industry's commercial model is undergoing one of its most significant transformations in decades. For years, pharmaceutical...
Clinical

Ionis and AstraZeneca falter as the ATTR-CM medication fails Phase 3

Antisense therapeutic AstraZeneca and Ionis Pharmaceuticals drug Wainua did not demonstrate a significant cardiovascular advantage in a Phase 3...
Regulatory

Merck Makes History By Getting FDA Green Light For Lipfendra

A decade after PCSK9 inhibitors first entered the market, the drug class has yet to fully meet the high...
Commercial

Vogenx Files for a Nasdaq Capital Market IPO to Fund Metabolic Drug

Vogenx is preparing to enter the public markets by...
Clinical

Axiom Reports Phase 1 Results for Stem Cell Therapy in Newborn Brain Injuries

Axiom Biosciences has reported results from a phase 1...
Commercial

AstraZeneca travels to China once more and purchases Dizal’s lung cancer medication for up to $1.5 billion

AstraZeneca has committed to spending up to $1.5 billion to partner with Dizal Pharmaceutical of China for an exclusive,...
Commercial

Spero Shells Out Over $1B For Innovent’s Autoimmune Antibody

Spero Therapeutics is reshaping its strategy by shifting its focus from antibiotics to immune and inflammatory diseases through a...
Research & Development

Biogen’s Phase 2 Diranersen Data Shows Reduced Cognitive Decline in Alzheimer’s Disease

Biogen has presented phase 2 results for diranersen, an investigational tau-targeting treatment for Alzheimer’s disease, reporting reductions in cognitive...
Regulatory

Merck Makes History By Getting FDA Green Light For Lipfendra

A decade after PCSK9 inhibitors first entered the market,...
Editorial Team -
Commercial

Gensenta sold to Eczacıbaşı in $135 million deal

Amgen will continue its operations in Turkey, serving the...
Commercial

Roche’s Acquisition of Spark Falls Short as Another Therapy Exits Pipeline

Roche’s 2019 acquisition of Philadelphia-based gene therapy specialist Spark...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

Regulatory

Regulatory

Merck Makes History By Getting FDA Green Light For Lipfendra

A decade after PCSK9 inhibitors first entered the market,...
Editorial Team -
Uncategorized

Sarclisa Escena Wins FDA Approval for Subcutaneous Use in Multiple Myeloma

Sanofi has received approval from the U.S. Food and...
Clinical

Bausch + Lomb Ends BL1107 Glaucoma Program After Phase 2 Trial Misses Main Goal

Bausch + Lomb has decided to discontinue development of...
Research & Development

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

The Advanced Research Projects Agency for Health (ARPA-H) has...
Commercial

GSK views the Hansoh-partnered ADCs’ phase 3 victory in China as confirming its “priority asset.”

Hansoh Pharmaceutical's two eagerly awaited ADCs have continued to...

Research & Development

Market Access

Manufacturing

Replimune Cuts 224 Jobs in Massachusetts After Second FDA Rejection of RP1

Replimune is reducing its workforce by 224 employees across...
Manufacturing

Vivtex Expands R&D and Workforce Following $2.1 Billion Novo Nordisk Partnership

Despite securing a partnership valued at up to $2.1...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Top 10 Metrics Pharma Leaders Should Track During Digital Transformation

Executive Summary Digital transformation has become one of the pharmaceutical...
Editorial Team -